DOI: 10.21276/ajptr
Tue, 21 May 2019

Proton Pump Inhibitors in Treatment of Peptic Ulcers


P.V. Gangurde1*, J. S. Rajawat1, C.S. Chauhan1, R. K. Kamble1.

1.Bhupal Nobels’ College of Pharmacy, Udaipur, Rajasthan, India



Acid-related disorders, including gastro esophageal reflux disease (GERD), duodenal ulcers, and gastric ulcers, are managed by H2 receptor antagonists and proton pump inhibitors (PPIs). PPIs represent first choice for treating acid-peptic ulcers inhibits the gastric- H+/ K+ -ATPase through covalent binding to cysteine residues of the proton pump. Achlorhydria and acute renal failure are the most common drawbacks. A reversible acid pump antagonist (APAs), currently in clinical trial removes these problems. The APAs are the conceivable future drugs for the treatment of acid-peptic disorders.

Keywords: Proton pump, Proton pump inhibitors, Acid secretion, Acid related disorders.

[PDF]   Viewed: 1447   Downloaded: 143
  • Call for paper

    American Journal of PharmTech Research (AJPTR) is a peer-reviewed, bimonthly official international journal allowing access to abstracts and full-text.



  • Email & SMS Alerts

    Email/SMS alert system is one of the key features and gives update information about the submitted manuscript.


  • Article Statastics

    American Journal of PharmTech Research (AJPTR) provides unique facility for authors to know popularity of articles on basis of numbers of PDF download and views. It will display in tabulated format.

  • Online Submission

    American Journal of PharmTech Research (AJPTR) is one of the International open access journal devoted to various disciplines in science and technology.


web counter
web counter